JP2015520196A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015520196A5 JP2015520196A5 JP2015516276A JP2015516276A JP2015520196A5 JP 2015520196 A5 JP2015520196 A5 JP 2015520196A5 JP 2015516276 A JP2015516276 A JP 2015516276A JP 2015516276 A JP2015516276 A JP 2015516276A JP 2015520196 A5 JP2015520196 A5 JP 2015520196A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue virus
- immunogenic composition
- administration
- immunogenic
- serotypes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 48
- 241000725619 Dengue virus Species 0.000 claims 34
- 230000002163 immunogen Effects 0.000 claims 32
- 238000009472 formulation Methods 0.000 claims 10
- 238000000034 method Methods 0.000 claims 9
- 206010012310 Dengue fever Diseases 0.000 claims 4
- 208000025729 dengue disease Diseases 0.000 claims 4
- 208000001490 Dengue Diseases 0.000 claims 3
- 230000001939 inductive effect Effects 0.000 claims 3
- 238000007918 intramuscular administration Methods 0.000 claims 3
- 238000007920 subcutaneous administration Methods 0.000 claims 3
- 238000011260 co-administration Methods 0.000 claims 2
- 230000003472 neutralizing effect Effects 0.000 claims 2
- 210000003484 anatomy Anatomy 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/492,884 | 2012-06-10 | ||
| US13/492,884 US8968996B2 (en) | 2009-06-01 | 2012-06-10 | Compositions and methods for rapid immunization against dengue virus |
| PCT/US2013/045041 WO2013188315A1 (en) | 2012-06-10 | 2013-06-10 | Compositions and methods for administration of vaccines against dengue virus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018030539A Division JP2018090618A (ja) | 2012-06-10 | 2018-02-23 | デングウイルスに対する免疫原性組成物およびワクチンキット |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015520196A JP2015520196A (ja) | 2015-07-16 |
| JP2015520196A5 true JP2015520196A5 (cg-RX-API-DMAC7.html) | 2016-07-28 |
Family
ID=48652375
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015516276A Pending JP2015520196A (ja) | 2012-06-10 | 2013-06-10 | デングウイルスに対するワクチン投与のための組成物および方法 |
| JP2018030539A Withdrawn JP2018090618A (ja) | 2012-06-10 | 2018-02-23 | デングウイルスに対する免疫原性組成物およびワクチンキット |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018030539A Withdrawn JP2018090618A (ja) | 2012-06-10 | 2018-02-23 | デングウイルスに対する免疫原性組成物およびワクチンキット |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2858668A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2015520196A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2915027A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ630831A (cg-RX-API-DMAC7.html) |
| TW (1) | TW201402143A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013188315A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2931310A4 (en) * | 2012-12-14 | 2016-05-25 | Takeda Vaccines Inc | COMPOSITIONS, METHODS OF ADMINISTRATION AND USES OF TRIVALENT FORMULATIONS AGAINST DENGUE VIRUS |
| FI3539565T3 (fi) | 2013-03-15 | 2023-04-19 | Takeda Vaccines Inc | Koostumuksia ja menetelmiä dengue-viruksen kimeerisille rakenteille rokotteissa |
| JP2018522880A (ja) | 2015-07-02 | 2018-08-16 | プライムヴァックス イミュノ−オンコロジー，インク． | デングウイルス及び樹状細胞による併用療法のための組成物及び方法 |
| MX2018003757A (es) | 2015-09-26 | 2018-09-21 | Primevax Immuno Oncology Inc | Composiciones y metodos para producir celulas dendriticas. |
| CN120392993A (zh) * | 2016-04-13 | 2025-08-01 | 武田疫苗股份有限公司 | 在儿童和年轻人中针对登革热病毒接种疫苗的组合物和方法 |
| TWI625393B (zh) * | 2016-11-15 | 2018-06-01 | 國立清華大學 | 對抗複數種登革熱病毒血清型之疫苗套組及其製備方法與用途 |
| CA3082779A1 (en) | 2016-11-16 | 2018-05-24 | PrimeVax Immuno-Oncology, Inc. | Combination immunotherapies for treatment of cancer |
| WO2018129202A1 (en) | 2017-01-04 | 2018-07-12 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for therapy with dengue virus |
| US11426461B2 (en) | 2018-09-05 | 2022-08-30 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis A |
| KR20210071979A (ko) | 2018-09-05 | 2021-06-16 | 다케다 백신즈 인코포레이티드 | 뎅기열 백신 단위 용량 및 이의 투여 |
| US11464815B2 (en) | 2018-09-05 | 2022-10-11 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8110196B2 (en) * | 2005-04-29 | 2012-02-07 | Polytopas LLC | Methods and compositions for polytopic vaccination |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| CA2763944A1 (en) * | 2009-06-01 | 2010-12-09 | Inviragen, Inc. | Compositions and methods for administration of vaccines against dengue virus |
| US8968996B2 (en) * | 2009-06-01 | 2015-03-03 | Takeda Vaccines, Inc. | Compositions and methods for rapid immunization against dengue virus |
-
2013
- 2013-06-10 WO PCT/US2013/045041 patent/WO2013188315A1/en not_active Ceased
- 2013-06-10 EP EP13729909.5A patent/EP2858668A1/en not_active Withdrawn
- 2013-06-10 TW TW102120553A patent/TW201402143A/zh unknown
- 2013-06-10 JP JP2015516276A patent/JP2015520196A/ja active Pending
- 2013-06-10 NZ NZ630831A patent/NZ630831A/en not_active IP Right Cessation
- 2013-06-10 CA CA2915027A patent/CA2915027A1/en not_active Abandoned
-
2018
- 2018-02-23 JP JP2018030539A patent/JP2018090618A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015520196A5 (cg-RX-API-DMAC7.html) | ||
| Levin et al. | Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same? | |
| ES2731899T3 (es) | Composición de vacuna nasal contra la gripe | |
| MX2021001762A (es) | Metodo y composicion para estimular la respuesta inmunitaria. | |
| AR096203A1 (es) | Dosificaciones y métodos para administrar moléculas de ácido nucleico formuladas en lípidos | |
| JP2012528794A5 (cg-RX-API-DMAC7.html) | ||
| JP2011525911A5 (cg-RX-API-DMAC7.html) | ||
| JP2018531984A5 (cg-RX-API-DMAC7.html) | ||
| JP2013126989A5 (cg-RX-API-DMAC7.html) | ||
| NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
| JP2017533972A5 (cg-RX-API-DMAC7.html) | ||
| JP2018505882A5 (cg-RX-API-DMAC7.html) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| NZ630831A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| Shakya et al. | Microneedle-mediated allergen-specific immunotherapy for the treatment of airway allergy in mice | |
| MX364800B (es) | Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca. | |
| JP2016531895A5 (cg-RX-API-DMAC7.html) | ||
| PH12013501373B1 (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
| JP2012001565A5 (cg-RX-API-DMAC7.html) | ||
| Shin et al. | Effect of zymosan and poly (I: C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine | |
| HRP20200142T1 (hr) | Postupci i sastavi za liječenje depresije uporabom ciklobenzaprina | |
| Kimoto et al. | Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice | |
| EA201592040A1 (ru) | Иммуногенная композиция для применения в терапии | |
| JP2016521754A5 (cg-RX-API-DMAC7.html) | ||
| JP2016531853A5 (cg-RX-API-DMAC7.html) |